RRx-001, a hypoxia-selective epigenetic agent and studied as a radio- and chem-sensitizer, triggers apoptosis and overcomes agent resistance in myeloma. RRx-001 exhibits potent anti-tumor activity with minimal toxicity[1]. RRx-001 is a dual small molecule checkpoint inhibitor by downregulating CD47 and SIRP-alpha[2]. RRx-001 is a potent inhibitor of G6PD and shows potent antimalarial activity[3].
Molecular Weight:
268.02
Purity:
99.79
CAS Number:
[925206-65-1]
Formula:
C5H6BrN3O5
Target:
Apoptosis,CD47,Parasite
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
